Dr. Shroff has focused her career on clinical and translational research in gastrointestinal malignancies. She has been principal investigator on a number of trials in pancreatic and biliary cancers. She has established herself a leading expert in biliary cancer and is the national P.I. on a pivotal, phase III study through SWOG in this disease. Dr. Shroff has authored many peer-reviewed publications in these areas and she has been invited to give multiple platform presentations on pancreatic and biliary cancers across the world. In addition, she is the leader of the Gastrointestinal (GI) Oncology Disease Oriented Team at the UA Cancer Center . This comprehensive program includes weekly multidisciplinary tumor board meetings, bi-monthly research meetings, and research collaborations with the Developmental Therapeutics/Phase 1 Program. She also serves as the chair of the UACC Data Safety and Monitoring Board given her experience with trial design and safety. Her vision for the Section of GI Medical Oncology is to continue providing cutting edge multidisciplinary care while developing a clinical trial portfolio that offers novel therapeutic options for all patients with GI malignancies.